van Dijk Louisa J D, Terlouw Luke G, van Noord Desirée, Bijdevaate Diederik C, Bruno Marco J, Moelker Adriaan
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; Department of Radiology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; Department of Radiology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
J Vasc Interv Radiol. 2020 Mar;31(3):430-437. doi: 10.1016/j.jvir.2019.10.019. Epub 2020 Jan 29.
To assess the ability of pressure measurements to discriminate clinically significant celiac artery (CA) or superior mesenteric artery (SMA) stenosis in patients with suspected chronic mesenteric ischemia (CMI).
Single-center, retrospective cohort study of 41 intra-arterial pressure measurements during mesenteric angiography with intended revascularization, performed in 37 patients (mean age 67.7 ± 10.8 years, 62% female) between April 2015 and May 2017. Simultaneous prestenotic and poststenotic pressure measurements had been obtained before and after intra-arterial administration of nitroglycerin. Revascularization was performed in 38 of 41 procedures. Definitive diagnosis of CMI was defined as patient-reported symptom relief or improvement after successful revascularization.
Pressure gradients obtained after vasodilator administration were significantly higher in CAs and SMAs with ≥50% stenosis. Pressure ratios (pressure distal [Pd]/pressure aorta [Pa]) obtained after vasodilator administration were significantly higher in CAs with ≥50% stenosis. Subgroup analysis of 22 patients with a ≥50% stenosis of either CA or SMA showed significantly higher pressure gradients and Pd/Pa ratios after vasodilator administration in CMI patients (median pressure gradient: CMI [interquartile ratio] 36 [21-40] mm Hg versus no-CMI 20 [9-21] mm Hg, P = 0.041; Pd/Pa: CMI 0.703 [0.598-0.769] versus no-CMI 0.827 [0.818-0.906], P = .009). A ≤0.8 Pd/Pa cutoff value after administration of a vasodilator best identified a clinically relevant stenosis, with 86% sensitivity and 83% specificity. Complications related to the pressure measurements were not observed.
Intra-arterial pressure measurements are feasible and safe. Low Pd/Pa ratios were associated with clinically relevant CA or SMA stenosis.
评估压力测量在鉴别疑似慢性肠系膜缺血(CMI)患者中具有临床意义的腹腔干(CA)或肠系膜上动脉(SMA)狭窄的能力。
对2015年4月至2017年5月期间37例患者(平均年龄67.7±10.8岁,62%为女性)进行的41次肠系膜血管造影术中动脉内压力测量进行单中心回顾性队列研究,这些测量旨在进行血管重建。在动脉内给予硝酸甘油前后,同时获得狭窄前和狭窄后的压力测量值。41例手术中有38例进行了血管重建。CMI的明确诊断定义为成功血管重建后患者报告的症状缓解或改善。
在狭窄≥50%的CA和SMA中,血管扩张剂给药后获得的压力梯度显著更高。血管扩张剂给药后获得的压力比值(远端压力[Pd]/主动脉压力[Pa])在狭窄≥50%的CA中显著更高。对22例CA或SMA狭窄≥50%的患者进行亚组分析显示,CMI患者在血管扩张剂给药后压力梯度和Pd/Pa比值显著更高(中位压力梯度:CMI[四分位间距]36[21 - 40]mmHg,非CMI为20[9 - 21]mmHg,P = 0.041;Pd/Pa:CMI为0.703[0.598 - 0.769],非CMI为0.827[0.818 - 0.906],P = 0.009)。血管扩张剂给药后Pd/Pa截止值≤0.8能最好地识别具有临床意义的狭窄,敏感性为86%,特异性为83%。未观察到与压力测量相关的并发症。
动脉内压力测量是可行且安全的。低Pd/Pa比值与具有临床意义的CA或SMA狭窄相关。